Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT04633967
Eligibility Criteria:
Inclusion Criteria: Patient s treated with Alemtuzumab as per canadian label -
Exclusion Criteria: Contraindication to Alemtuzumab
\-
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04633967
Study Brief:
Protocol Section:
NCT04633967